Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods of treating PR-positive, luminal A breast cancer with PI3K inhibitor, pictilisib

Methods of treating PR-positive, luminal A breast cancer with PI3K inhibitor, pictilisib

US Patent 10004748 · Granted Jun 26, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Treatment of breast cancer using combination therapies comprising GDC-9545 and a2025
HER-2 targeted bispecific compositions and methods for making and using the same2025
Treatment of breast cancer using combination therapies comprising GDC-9545 and a2024
Methods and compositions for modulating estrogen receptor mutants2018
Combinations of phosphoinositide 3-kinase inhibitor compounds and chemotherapeut2016
Mutant selectivity and combinations of a phosphoinositide 3-kinase inhibitor com2015
SCDs as modifiers of the p53 pathway and methods of use2014
Extending time to disease progression or survival in cancer patients2014
EEF2K as modifiers of the PTEN/AKT pathway and methods of use2014
Combinations of phosphoinositide 3-kinase inhibitor compounds chemotherapeutic a2013
Combinations of phosphoinositide 3-kinase inhibitor compounds and chemotherapeut2013
RORS as modifiers of the p21 pathway and methods of use2013